ALKBH5 and breast cancer: The knockdown of ZNF217 and ALKBH5 increased m6A modification and inhibited hypoxia-induced expression of the pluripotent stem cell factors NANOG and KLF4, thereby suppressing the pluripotency of BC cells (Zhang et al., 2016b).